Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00968565 · ClinicalTrials.gov registry record · Early Phase 1
Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)
A Early Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 2
- Enrollment target
NCT00968565 is a Early Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 2 participants.
The verdict
NCT00968565, a Early Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and efficacy of citrate to provide anticoagulation of an ECMO circuit without patient anticoagulation. The standard method of providing ECMO circuit anticoagulation is the use of heparin which also anticoagulates the patient and increases the risk of patient bleeding.
Interventions
- DRUG sodium citrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2010-01 |
| Est. Completion | 2015-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00968565
The ClinicalTrials.gov registry entry for NCT00968565 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium citrate is the first listed.
NCT00968565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00968565 about?
NCT00968565 is a clinical study titled "Study Using Citrate to Replace Heparin in Babies Requiring Extracorporeal Membrane Oxygenation (ECMO)". The purpose of this study is to determine the safety and efficacy of citrate to provide anticoagulation of an ECMO circuit without patient anticoagulation. The standard method of providing ECMO circuit anticoagulation is the use of heparin which also anticoagulates the patient and increases the risk...
What is the current status of trial NCT00968565?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 2 participants. The study started on 2010-01. Estimated completion is 2015-06.
What interventions are being tested in trial NCT00968565?
The interventions under investigation include: sodium citrate (DRUG).
Who is sponsoring clinical trial NCT00968565?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.